Review



trypan blue cell viability assay  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher trypan blue cell viability assay
    (A) Schematic of BCL-X exon 2 and position of intron response element (IRE). (B) RNAseq and DESeq2 analysis of GEnCs treated with glucose soup (GS) showed a significant increase in the IL-6 read counts compared to mannitol (MAN) control (n = 5; *p < 0.05). (C) The increase in IL-6 expression in response to GS was confirmed with qRT-PCR, which persisted in the absence of IL-6 from the GS treatment of GEnCs (n = 3; *p < 0.05 vs. mannitol control as assessed by one-way ANOVA and Tukey post-hoc test). (D) Treatment of GEnCs for 6 h with increasing concentrations of IL-6 alone resulted in a dose-dependent increase in BCL-XS/BCL-XL (n = 3; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (E) IL-6 dose-dependently increased the fluorescence green/red (520/590 nm) ratio, representing an increase in <t>cell</t> apoptosis, using the JC-10 <t>assay</t> (n = 4; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (F) IL-6 dose-dependently increased caspase activation (n = 4; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (G) IL-6 dose-dependently decreased cell <t>viability,</t> as assessed with <t>Trypan</t> <t>blue</t> staining, indicating increased cell apoptosis with increasing IL-6 (n = 4; *p < 0.05 as assessed by one-way ANOVA).
    Trypan Blue Cell Viability Assay, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/trypan+blue+cell+viability+assay/bio_rxiv__2025__06__06__658276-66-0-5?v=Thermo+Fisher
    Average 90 stars, based on 1 article reviews
    trypan blue cell viability assay - by Bioz Stars, 2026-07
    90/100 stars

    Images

    1) Product Images from "The apoptosis gene BCL-X splice isoforms have opposing effects in diabetic kidney disease: potential treatment target and prognostic value"

    Article Title: The apoptosis gene BCL-X splice isoforms have opposing effects in diabetic kidney disease: potential treatment target and prognostic value

    Journal: bioRxiv

    doi: 10.1101/2025.06.06.658276

    (A) Schematic of BCL-X exon 2 and position of intron response element (IRE). (B) RNAseq and DESeq2 analysis of GEnCs treated with glucose soup (GS) showed a significant increase in the IL-6 read counts compared to mannitol (MAN) control (n = 5; *p < 0.05). (C) The increase in IL-6 expression in response to GS was confirmed with qRT-PCR, which persisted in the absence of IL-6 from the GS treatment of GEnCs (n = 3; *p < 0.05 vs. mannitol control as assessed by one-way ANOVA and Tukey post-hoc test). (D) Treatment of GEnCs for 6 h with increasing concentrations of IL-6 alone resulted in a dose-dependent increase in BCL-XS/BCL-XL (n = 3; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (E) IL-6 dose-dependently increased the fluorescence green/red (520/590 nm) ratio, representing an increase in cell apoptosis, using the JC-10 assay (n = 4; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (F) IL-6 dose-dependently increased caspase activation (n = 4; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (G) IL-6 dose-dependently decreased cell viability, as assessed with Trypan blue staining, indicating increased cell apoptosis with increasing IL-6 (n = 4; *p < 0.05 as assessed by one-way ANOVA).
    Figure Legend Snippet: (A) Schematic of BCL-X exon 2 and position of intron response element (IRE). (B) RNAseq and DESeq2 analysis of GEnCs treated with glucose soup (GS) showed a significant increase in the IL-6 read counts compared to mannitol (MAN) control (n = 5; *p < 0.05). (C) The increase in IL-6 expression in response to GS was confirmed with qRT-PCR, which persisted in the absence of IL-6 from the GS treatment of GEnCs (n = 3; *p < 0.05 vs. mannitol control as assessed by one-way ANOVA and Tukey post-hoc test). (D) Treatment of GEnCs for 6 h with increasing concentrations of IL-6 alone resulted in a dose-dependent increase in BCL-XS/BCL-XL (n = 3; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (E) IL-6 dose-dependently increased the fluorescence green/red (520/590 nm) ratio, representing an increase in cell apoptosis, using the JC-10 assay (n = 4; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (F) IL-6 dose-dependently increased caspase activation (n = 4; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (G) IL-6 dose-dependently decreased cell viability, as assessed with Trypan blue staining, indicating increased cell apoptosis with increasing IL-6 (n = 4; *p < 0.05 as assessed by one-way ANOVA).

    Techniques Used: Control, Expressing, Quantitative RT-PCR, Fluorescence, Activation Assay, Staining



    Similar Products

    96
    Bio-Rad cell viability
    Cell Viability, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/trypan+blue+cell+viability+assay/pmc12563272-240-0-11?v=Bio-Rad
    Average 96 stars, based on 1 article reviews
    cell viability - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    99
    Beyotime trypan blue staining cell viability assay kit
    Trypan Blue Staining Cell Viability Assay Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/trypan+blue+cell+viability+assay/pm40773895-63-12-20?v=Beyotime
    Average 99 stars, based on 1 article reviews
    trypan blue staining cell viability assay kit - by Bioz Stars, 2026-07
    99/100 stars
      Buy from Supplier

    90
    Thermo Fisher trypan blue cell viability assay
    (A) Schematic of BCL-X exon 2 and position of intron response element (IRE). (B) RNAseq and DESeq2 analysis of GEnCs treated with glucose soup (GS) showed a significant increase in the IL-6 read counts compared to mannitol (MAN) control (n = 5; *p < 0.05). (C) The increase in IL-6 expression in response to GS was confirmed with qRT-PCR, which persisted in the absence of IL-6 from the GS treatment of GEnCs (n = 3; *p < 0.05 vs. mannitol control as assessed by one-way ANOVA and Tukey post-hoc test). (D) Treatment of GEnCs for 6 h with increasing concentrations of IL-6 alone resulted in a dose-dependent increase in BCL-XS/BCL-XL (n = 3; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (E) IL-6 dose-dependently increased the fluorescence green/red (520/590 nm) ratio, representing an increase in <t>cell</t> apoptosis, using the JC-10 <t>assay</t> (n = 4; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (F) IL-6 dose-dependently increased caspase activation (n = 4; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (G) IL-6 dose-dependently decreased cell <t>viability,</t> as assessed with <t>Trypan</t> <t>blue</t> staining, indicating increased cell apoptosis with increasing IL-6 (n = 4; *p < 0.05 as assessed by one-way ANOVA).
    Trypan Blue Cell Viability Assay, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/trypan+blue+cell+viability+assay/bio_rxiv__2025__06__06__658276-66-0-5?v=Thermo+Fisher
    Average 90 stars, based on 1 article reviews
    trypan blue cell viability assay - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher trypan blue cell viability assay t10282
    (A) Schematic of BCL-X exon 2 and position of intron response element (IRE). (B) RNAseq and DESeq2 analysis of GEnCs treated with glucose soup (GS) showed a significant increase in the IL-6 read counts compared to mannitol (MAN) control (n = 5; *p < 0.05). (C) The increase in IL-6 expression in response to GS was confirmed with qRT-PCR, which persisted in the absence of IL-6 from the GS treatment of GEnCs (n = 3; *p < 0.05 vs. mannitol control as assessed by one-way ANOVA and Tukey post-hoc test). (D) Treatment of GEnCs for 6 h with increasing concentrations of IL-6 alone resulted in a dose-dependent increase in BCL-XS/BCL-XL (n = 3; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (E) IL-6 dose-dependently increased the fluorescence green/red (520/590 nm) ratio, representing an increase in <t>cell</t> apoptosis, using the JC-10 <t>assay</t> (n = 4; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (F) IL-6 dose-dependently increased caspase activation (n = 4; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (G) IL-6 dose-dependently decreased cell <t>viability,</t> as assessed with <t>Trypan</t> <t>blue</t> staining, indicating increased cell apoptosis with increasing IL-6 (n = 4; *p < 0.05 as assessed by one-way ANOVA).
    Trypan Blue Cell Viability Assay T10282, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/trypan+blue+cell+viability+assay/pm40434957-122-25-31?v=Thermo+Fisher
    Average 90 stars, based on 1 article reviews
    trypan blue cell viability assay t10282 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher trypan blue cell viability assay reagents
    (A) Schematic of BCL-X exon 2 and position of intron response element (IRE). (B) RNAseq and DESeq2 analysis of GEnCs treated with glucose soup (GS) showed a significant increase in the IL-6 read counts compared to mannitol (MAN) control (n = 5; *p < 0.05). (C) The increase in IL-6 expression in response to GS was confirmed with qRT-PCR, which persisted in the absence of IL-6 from the GS treatment of GEnCs (n = 3; *p < 0.05 vs. mannitol control as assessed by one-way ANOVA and Tukey post-hoc test). (D) Treatment of GEnCs for 6 h with increasing concentrations of IL-6 alone resulted in a dose-dependent increase in BCL-XS/BCL-XL (n = 3; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (E) IL-6 dose-dependently increased the fluorescence green/red (520/590 nm) ratio, representing an increase in <t>cell</t> apoptosis, using the JC-10 <t>assay</t> (n = 4; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (F) IL-6 dose-dependently increased caspase activation (n = 4; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (G) IL-6 dose-dependently decreased cell <t>viability,</t> as assessed with <t>Trypan</t> <t>blue</t> staining, indicating increased cell apoptosis with increasing IL-6 (n = 4; *p < 0.05 as assessed by one-way ANOVA).
    Trypan Blue Cell Viability Assay Reagents, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/trypan+blue+cell+viability+assay/pm39966174-63-5-11?v=Thermo+Fisher
    Average 90 stars, based on 1 article reviews
    trypan blue cell viability assay reagents - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A) Schematic of BCL-X exon 2 and position of intron response element (IRE). (B) RNAseq and DESeq2 analysis of GEnCs treated with glucose soup (GS) showed a significant increase in the IL-6 read counts compared to mannitol (MAN) control (n = 5; *p < 0.05). (C) The increase in IL-6 expression in response to GS was confirmed with qRT-PCR, which persisted in the absence of IL-6 from the GS treatment of GEnCs (n = 3; *p < 0.05 vs. mannitol control as assessed by one-way ANOVA and Tukey post-hoc test). (D) Treatment of GEnCs for 6 h with increasing concentrations of IL-6 alone resulted in a dose-dependent increase in BCL-XS/BCL-XL (n = 3; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (E) IL-6 dose-dependently increased the fluorescence green/red (520/590 nm) ratio, representing an increase in cell apoptosis, using the JC-10 assay (n = 4; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (F) IL-6 dose-dependently increased caspase activation (n = 4; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (G) IL-6 dose-dependently decreased cell viability, as assessed with Trypan blue staining, indicating increased cell apoptosis with increasing IL-6 (n = 4; *p < 0.05 as assessed by one-way ANOVA).

    Journal: bioRxiv

    Article Title: The apoptosis gene BCL-X splice isoforms have opposing effects in diabetic kidney disease: potential treatment target and prognostic value

    doi: 10.1101/2025.06.06.658276

    Figure Lengend Snippet: (A) Schematic of BCL-X exon 2 and position of intron response element (IRE). (B) RNAseq and DESeq2 analysis of GEnCs treated with glucose soup (GS) showed a significant increase in the IL-6 read counts compared to mannitol (MAN) control (n = 5; *p < 0.05). (C) The increase in IL-6 expression in response to GS was confirmed with qRT-PCR, which persisted in the absence of IL-6 from the GS treatment of GEnCs (n = 3; *p < 0.05 vs. mannitol control as assessed by one-way ANOVA and Tukey post-hoc test). (D) Treatment of GEnCs for 6 h with increasing concentrations of IL-6 alone resulted in a dose-dependent increase in BCL-XS/BCL-XL (n = 3; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (E) IL-6 dose-dependently increased the fluorescence green/red (520/590 nm) ratio, representing an increase in cell apoptosis, using the JC-10 assay (n = 4; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (F) IL-6 dose-dependently increased caspase activation (n = 4; *p < 0.05 vs. 0 ng/ml IL-6 as assessed by one-way ANOVA and Tukey post-hoc test). (G) IL-6 dose-dependently decreased cell viability, as assessed with Trypan blue staining, indicating increased cell apoptosis with increasing IL-6 (n = 4; *p < 0.05 as assessed by one-way ANOVA).

    Article Snippet: Trypan blue cell viability assay (ThermoFisher Scientific): Trypan blue stain colors dead cells blue, allowing cell viability to be measured.

    Techniques: Control, Expressing, Quantitative RT-PCR, Fluorescence, Activation Assay, Staining